NCT06875375

The Role of Probiotic LH76 in Human Gut Health

A Clinical Study on the Safety and Efficacy of Probiotic LH76 in Modulating Gut Microbiota and Enhancing Intestinal Health in Healthy Adults

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the safety and efficacy of the probiotic LH76 as a dietary supplement in healthy adults. The research will assess its effects on gut microbiota composition, intestinal health, and immune function compared to a placebo. Key outcomes include changes in microbial diversity, intestinal barrier integrity, and immune response markers over the intervention period. The findings will contribute to understanding the potential health benefits of LH76 and its role in supporting gut and immune health.

Conditions

• Gut Microbiota Modulation

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	probiotic LH76	Intervention with LH76 (30 billion CFU/ day, 3g) was administered daily for 8 weeks. Store in a cool, dry place.
DIETARY_SUPPLEMENT	Placebo	Every day to give 3 g maltodextrin intervention for 8 weeks. Store in a cool and dry place.

Timeline

• Start date: 2025-05-11
• Primary completion: 2025-05-20
• Completion: 2025-10-26
• First posted: 2025-03-13
• Last updated: 2025-03-18